Similar articles for PMID: 33517271

Year	Number of Results
2000	1
2002	1
2005	1
2006	4
2007	1
2008	2
2009	7
2010	3
2011	8
2012	5
2013	8
2014	9
2015	12
2016	5
2017	7
2018	9
2019	23
2020	7
2021	1

1

YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation.

Kim HJ, Heo K. Kim HJ, et al. Anticancer Res. 2021 Feb;41(2):671-678. doi: 10.21873/anticanres.14818. Anticancer Res. 2021. PMID: 33517271

2

Preclinical development of a humanized neutralizing antibody targeting HGF.

Kim H, Hong SH, Kim JY, Kim IC, Park YW, Lee SJ, Song SW, Kim JJ, Park G, Kim TM, Kim YH, Park JB, Chung J, Kim IH. Kim H, et al. Exp Mol Med. 2017 Mar 24;49(3):e309. doi: 10.1038/emm.2017.21. Exp Mol Med. 2017. PMID: 28336956 Free PMC article.

3

Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression.

Kim HJ, Lee S, Oh YS, Chang HK, Kim YS, Hong SH, Kim JY, Park YW, Lee SJ, Song SW, Kim JJ, Heo K. Kim HJ, et al. Front Oncol. 2019 Jul 9;9:571. doi: 10.3389/fonc.2019.00571. eCollection 2019. Front Oncol. 2019. PMID: 31355133 Free PMC article.

4

Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment.

Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Kwon Y, et al. Oncogene. 2015 Jan 8;34(2):144-53. doi: 10.1038/onc.2013.539. Epub 2013 Dec 23. Oncogene. 2015. PMID: 24362531 Free PMC article.

5

CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.

Deying W, Feng G, Shumei L, Hui Z, Ming L, Hongqing W. Deying W, et al. Biosci Rep. 2017 Apr 10;37(2):BSR20160470. doi: 10.1042/BSR20160470. Print 2017 Apr 28. Biosci Rep. 2017. PMID: 28258248 Free PMC article.

6

Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.

Pothula SP, Xu Z, Goldstein D, Biankin AV, Pirola RC, Wilson JS, Apte MV. Pothula SP, et al. Br J Cancer. 2016 Feb 2;114(3):269-80. doi: 10.1038/bjc.2015.478. Epub 2016 Jan 14. Br J Cancer. 2016. PMID: 26766740 Free PMC article.

7

Inhibition of tumor growth in a mouse xenograft model by the humanized anti-HGF monoclonal antibody YYB-101 produced in a large-scale CHO cell culture.

Song SW, Lee SJ, Kim CY, Song JK, Jung EJ, Choi YB, Min SW, Oh JW. Song SW, et al. J Microbiol Biotechnol. 2013 Sep 28;23(9):1327-38. doi: 10.4014/jmb.1306.06007. J Microbiol Biotechnol. 2013. PMID: 23851271 Free article.

8

Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.

Sa JK, Kim SH, Lee JK, Cho HJ, Shin YJ, Shin H, Koo H, Kim D, Lee M, Kang W, Hong SH, Kim JY, Park YW, Song SW, Lee SJ, Joo KM, Nam DH. Sa JK, et al. Neuro Oncol. 2019 Feb 14;21(2):222-233. doi: 10.1093/neuonc/noy105. Neuro Oncol. 2019. PMID: 29939324 Free PMC article.

9

HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.

Bu R, Uddin S, Bavi P, Hussain AR, Al-Dayel F, Ghourab S, Ahmed M, Al-Kuraya KS. Bu R, et al. Lab Invest. 2011 Jan;91(1):124-37. doi: 10.1038/labinvest.2010.136. Epub 2010 Jul 26. Lab Invest. 2011. PMID: 20661229

10

Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.

Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L. Zhao Y, et al. Drug Des Devel Ther. 2015 Aug 26;9:4897-907. doi: 10.2147/DDDT.S85837. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26345996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed